Just as governments around the world have spent the past year racing to get the coronavirus pandemic under control, we should be racing to contend with a similarly harmful global event: the threat of ...

Few big biotech firms have been as successful recently as Celgene. The maker of multiple myeloma home run drug Revlimid has seen its shares rocket higher by more than 38% over the last three months ...

Portfolio construction is crucial for any investor, whether a beginner or experienced, as it helps balance risk and maximize returns. The key is to ensure each investment serves a specific purpose ...

If you had stitched together a sound, well-conceived investment plan before the financial crisis hit, you stood a much better chance of staying invested through the bear market than if you had ...